Adagene Inc. American Depositary Shares (ADAG) Stock Price
ADAGStock
$3.82+63.18%52W
Market Cap$252.40M
P/E—
PEG Ratio—
Div yield—
Beta0.55
ADAG Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)7.29%
Price vs S&P 500 (4W)1.51%
VGM Score61.23
ADAG Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.15
4.17
4.17
4.15
Industry Peers — Pharmaceuticals(571)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ADAGAdagene Inc. American Depositary Shares | D | A | C | $3.82 |
| LLYEli Lilly & Co. | D | B | B | $1233.66 |
| JNJJohnson & Johnson | D | C | B | $273.14 |
| ABBVABBVIE INC. | D | C | B | $265.79 |
| MRKMerck & Co., Inc. | D | C | A | $156.45 |
| NVSNovartis AG | C | C | C | $159.98 |
| AZNAstraZeneca PLC | C | B | C | $169.66 |
| NVONovo-Nordisk A/S | B | C | C | $48.66 |
| ABTAbbott Laboratories | C | C | B | $116.13 |
| PFEPfizer Inc. | C | D | C | $28.57 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $552.85 |
About Adagene Inc. American Depositary Shares
Adagene is a clinical-stage biopharmaceutical company developing monoclonal antibody immunotherapies for cancer treatment. The company's proprietary platform generates therapeutic antibody candidates with enhanced functional epitopes and species cross-reactivity, enabling a differentiated pipeline of cancer immunotherapy programs.